A NOTCH4 association with multiple sclerosis is secondary to HLA-DR*1501

Tissue Antigens

Volumn 63, Issue 1, 2004, Pages 13-20

  Duvefelt, K ^a   Anderson, M ^a   Fogdell Hahn, A ^a   Hillert, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Genetic susceptibility; Multiple sclerosis; NOTCH4; TNF

Indexed keywords

HLA A ANTIGEN; HLA DR ANTIGEN; NOTCH RECEPTOR; NOTCH4 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE; TRINUCLEOTIDE REPEAT;

ALLELES; CENTRAL NERVOUS SYSTEM; HAPLOTYPES; HLA-A ANTIGENS; HLA-DR ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, NOTCH; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1642439875     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2004.00135.x     Document Type: Article

References (37)

1. Ligers A, Dyment DA, Willer CJ et al. Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis. Am J Hum Genet 2001: 69: 900-3.
2. Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 2000: 55: 140-8.
3. Rubio JP, Bahlo M, Butzkueven H et al. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am J Hum Genet 2002: 70: 1125-37.
4. Iso T, Hamamori Y, Kedes L. Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 2003: 23: 543-53.
5. Uyttendaele H, Ho J, Rossant J, Kitajewski J. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci USA 2001: 98: 5643-8.
6. John GR, Shankar SL, Shafit-Zagardo B et al. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 2002: 8: 1115-21.
7. Wei J, Hemmings GP. The NOTCH4 locus is associated with susceptibility to schizophrenia. Nat Genet 2000: 25: 376-7.
8. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992: 10: 411-52.
9. Hauser SL. Tumor necrosis factor: immunogenetics and disease. Ann Neurol 1995: 38: 702-4.
10. Rieckmann P, Albrecht M, Kitze B et al. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 1994: 44: 1523-6.
11. Rieckmann P, Albrecht M, Kitze B et al. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Am Neurol 1995: 37: 82-8.
12. Roth MP, Nogueira L, Coppin H, Clanet M, Clayton J, Cambon-Thomsen A. Tumor necrosis factor polymorphism in multiple sclerosis: no additional association independent of HLA. J Neuroimmunol 1994: 51: 93-9.
13. Sandberg-Wollheim M, Ciusani E, Salmaggi A, Pociot F. An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis. Mult Scler 1995: 1: 181-5.
14. Kirk CW, Droogan AG, Hawkins SA, McMillan SA, Nevin NC, Graham CA. Tumour necrosis factor microsatellites show association with multiple sclerosis. J Neurol Sci 1997: 147: 21-5.
15. Allcock RJ, de la Concha EG, Fernandez-Arquero M et al. Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster. Hum Immunol 1999: 60: 1266-73.
16. Lucotte G, Bathelier C, Mercier G. TNF-alpha polymorphisms in multiple sclerosis: no association with -238 and -308 promoter alleles, but the microsatellite allele all is associated with the disease in French patients. Mult Scler 2000: 6: 78-80.
17. Mycko M, Kowalski W, Kwinkowski M et al. Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha. J Neuroimmunol 1998: 84: 198-206.
18. Braun N, Michel U, Ernst BP et al. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production. Neurosci Lett 1996: 215: 75-8.
19. He B, Navikas V, Lundahl J, Soderstrom M, Hillert J. Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis. J Neuroimmunol 1995: 63: 143-7.
20. Huizinga TW, Westendorp RG, Bollen EL et al. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997: 72: 149-53.
21. Fernandez-Arquero M, Arroyo R, Rubio A et al. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology 1999: 53: 1361-3.
22. Hajeer AH, Hutchinson IV. TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Technol 2000: 50: 216-28.
23. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983: 13: 227-31.
24. Lee LG, Connell CR, Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res 1993: 21: 3761-6.
25. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995: 59: 97-105.
26. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994: 43: 18-27.
27. Sklar P, Schwab SG, Williams NM et al. Association analysis of NOTCH4 loci in schizophrenia using family and population-based controls. Nat Genet 2001: 28: 126-8.
28. McGinnis RE, Fox H, Yates P et al. Failure to confirm NOTCH4 association with schizophrenia in a large population-based sample from Scotland. Nat Genet 2001: 28: 128-9.
29. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/ MRI Analysis Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 1999: 53: 457-65.
30. McDonnell GV, Kirk CW, Middleton D et al. Genetic association studies of tumour necrosis factor alpha and beta and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis. J Neurol 1999: 246: 1051-8.
31. Ma JJ, Nishimura M, Mine H et al. HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis. J Neuroimmunol 1998: 92: 109-12.
32. Craandijk J, van Krugten MV, Verweij CL, van der Velden U, Loos BG. Tumor necrosis factor-alpha gene polymorphisms in relation to periodontitis. J Clin Periodontol 2002: 29: 28-34.
33. Weinshenker BG, Hebrink DD, Atkinson E, Kantarci OH. Association of a tumor necrosis factor alpha polymorphism with MS susceptibility. Neurology 2001: 57: 1341-2.
34. Johnson GC, Esposito L, Barratt BJ et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001: 29: 233-7.
35. Martin ER, Lai EH, Gilbert JR et al. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet 2000: 67: 383-94.
36. Yan H, Papadopoulos N, Marra G et al. Conversion of diploidy to haploidy. Nature 2000: 403: 723-4.
37. Niu T, Qin ZS, Xu X, Liu JS. Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am J Hum Genet 2002: 70: 157-69.